THE THERAPEUTIC EFFECTS OF 4-METHYLCATECHOL, A STIMULATOR OF ENDOGENOUS NERVE GROWTH-FACTOR SYNTHESIS, ON EXPERIMENTAL DIABETIC NEUROPATHY IN RATS

被引：44

作者：

HANAOKA, Y ^{[1
]}

OHI, T ^{[1
]}

FURUKAWA, S ^{[1
]}

FURUKAWA, Y ^{[1
]}

HAYASHI, K ^{[1
]}

MATSUKURA, S ^{[1
]}

机构：

[1] GIFU PHARMACEUT UNIV, DEPT MOLEC BIOL, GIFU, JAPAN

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 1994年 / 122卷 / 01期

关键词：

4-METHYLCATECHOL; NERVE GROWTH FACTOR; EXPERIMENTAL DIABETIC NEUROPATHY; MOTOR NERVE CONDUCTION VELOCITY; MORPHOMETRICAL ANALYSIS;

D O I：

10.1016/0022-510X(94)90048-5

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We investigated therapeutic effects of 4-methylcatechol (4-MC), a non-amine catechol compound, on streptozotocin (STZ)-induced diabetic neuropathy in rats. 4-MC is one of the potent stimulators of endogenous nerve growth factor (NGF) synthesis both in vitro and in vivo. Diabetic rats showed a statistically significant reduction in motor nerve conduction velocity (MNCV), mean myelinated axon diameter, and NGF content in the sciatic nerve during the experimental period of 8 weeks. The 4-MC treatment started 4 weeks after the STZ injection resulted in significantly greater NGF content, faster MNCV, and larger mean myelinated nerve fiber diameter and axon diameter than in untreated diabetic rats. These findings suggest that a decreased NGF level in the diabetic sciatic nerves may be involved in the pathogenesis of diabetic neuropathy and that 4-MC treatment could be useful for diabetic neuropathy.

引用

页码：28 / 32

页数：5

共 31 条

[1] ARAKAWA Y, 1990, J NEUROSCI, V10, P3507
[2] FACIAL-NERVE REGENERATION IN THE SILICONE CHAMBER - THE INFLUENCE OF NERVE GROWTH-FACTOR
CHEN, YS
WANGBENNETT, LT
COKER, NJ
[J]. EXPERIMENTAL NEUROLOGY, 1989, 103 (01) : 52 - 60
[3] IMPAIRED NERVE REGENERATION IN STREPTOZOTOCIN-DIABETIC RATS - EFFECTS OF TREATMENT WITH AN ALDOSE REDUCTASE INHIBITOR
EKSTROM, PAR
TOMLINSON, DR
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1989, 93 (2-3) : 231 - 237
[4] FURUKAWA S, 1990, CEREBROVAS BRAIN MET, V2, P328
[5] A HIGHLY SENSITIVE ENZYME-IMMUNOASSAY FOR MOUSE BETA-NERVE GROWTH-FACTOR
FURUKAWA, S
KAMO, I
FURUKAWA, Y
AKAZAWA, S
SATOYOSHI, E
ITOH, K
HAYASHI, K
[J]. JOURNAL OF NEUROCHEMISTRY, 1983, 40 (03) : 734 - 744
[6] CATECHOLAMINES INCREASE NERVE GROWTH-FACTOR MESSENGER-RNA CONTENT IN BOTH MOUSE ASTROGLIAL CELLS AND FIBROBLAST CELLS
FURUKAWA, Y
TOMIOKA, N
SATO, W
SATOYOSHI, E
HAYASHI, K
FURUKAWA, S
[J]. FEBS LETTERS, 1989, 247 (02) : 463 - 467
[7] STIMULATORY EFFECT OF 4-ALKYLCATECHOLS AND THEIR DIACETYLATED DERIVATIVES ON THE SYNTHESIS OF NERVE GROWTH-FACTOR
FURUKAWA, Y
FUKAZAWA, N
MIYAMA, Y
HAYASHI, K
FURUKAWA, S
[J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) : 2337 - 2342
[8] GREENE DA, 1987, NEW ENGL J MED, V316, P599
[9] EFFECT OF 4-METHYLCATECHOL ON SCIATIC-NERVE GROWTH-FACTOR LEVEL AND MOTOR-NERVE CONDUCTION-VELOCITY IN EXPERIMENTAL DIABETIC NEUROPATHIC PROCESS IN RATS
HANAOKA, Y
OHI, T
FURUKAWA, S
FURUKAWA, Y
HAYASHI, K
MATSUKURA, S
[J]. EXPERIMENTAL NEUROLOGY, 1992, 115 (02) : 292 - 296
[10] ENDOGENOUS LEVELS OF NERVE GROWTH-FACTOR (NGF) ARE ALTERED IN EXPERIMENTAL DIABETES-MELLITUS - A POSSIBLE ROLE FOR NGF IN THE PATHOGENESIS OF DIABETIC NEUROPATHY
HELLWEG, R
HARTUNG, HD
[J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 26 (02) : 258 - 267

← 1 2 3 4 →